Status:

UNKNOWN

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Lead Sponsor:

Sun Yat-sen University

Collaborating Sponsors:

Nestle Health Science

Conditions:

Nasopharyngeal Carcinoma

Nutritional Support

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

PHASE3

Brief Summary

Radiation therapy remains the principal treatment for nasopharyngeal carcinoma (NPC). The most frequently occurred radiation-related side effect is probably the radiation-induced oral mucositis, which...

Detailed Description

Radiation therapy remains the principal treatment for nasopharyngeal carcinoma (NPC). The most frequently occurred radiation-related side effect is probably the radiation-induced oral mucositis, which...

Eligibility Criteria

Inclusion

  • Pathologically confirmed and previously untreated nasopharyngeal carcinoma without distant metastasis.
  • Age ≥ 18 years and \< 65 years.
  • Karnofsky performance status (KPS) score ≥ 70.
  • Planned to receive radiotherapy alone or concurrent chemoradiotherapy, with intensity-modulated radiation therapy (IMRT).
  • Adequate normal organ function.
  • Well nutritional status, with PG-SGA≤1 score and NRS2002\<3 scores.
  • Without other severe diseases.
  • Signed informed consent voluntarily, and could complete required oral nutrition, questionnaire survey and follow-up.

Exclusion

  • Known allergic reaction to any component of Nutren® Optimum, or severe allergic constitution.
  • Poor compliance.
  • Other conditions that the investigators consider as inappropriate for enrolling into this study.

Key Trial Info

Start Date :

January 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2021

Estimated Enrollment :

408 Patients enrolled

Trial Details

Trial ID

NCT03344068

Start Date

January 1 2018

End Date

March 31 2021

Last Update

December 22 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Radiation Oncology, Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China, 510060